288 Supplementary Figure S2 (A-D) | Distributions of serum concentrations of (A) interferon-gamma (IFN-γ), (B) serum amyloid A (SAA), (C) interleukin-6 (IL-6) and (D) interleukin-17A (IL-17A), that were significantly different among binary categorized endoscopic disease activity (remission (0) or mild (1) disease vs. moderate (2) or severe (3) disease), using the Simple Endoscopic Score for Crohn’s disease (SES-CD). *P < 0.05. **P < 0.01. SupplementaryFigureS3 (A-D) | Discriminativecapacityof (A) serumamyloidA (SAA), (B) interferon-gamma (IFN-γ), (C) interleukin-6 (IL-6) and (D) interleukin-17A (IL-17A) regarding binary categorized endoscopic disease activity in CD (remission (0) or mild (1) vs. moderate (2) or severe (3) disease) as represented by the area under the receiver operating characteristics curve (AuROC). Of all individual molecules shown, SAA displayed the best discriminative capacity regarding binary ordered SES-CD endoscopic disease activity. Chapter 8
RkJQdWJsaXNoZXIy MjY0ODMw